(Q44823961)

6 December 2017

title

Quinolone use and resistance (English)

1 reference

6 December 2017

0 references

Jesús Oteo

1

1 reference

6 December 2017

José Campos

series ordinal

2

1 reference

6 December 2017

language of work or name

Spanish

0 references

publication date

1 April 2004

1 reference

Infectious Diseases and Clinical Microbiology

6 December 2017

published in

1 reference

6 December 2017

volume

22

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

201-203

1 reference

Risk factor assessment for the acquisition of fluoroquinolone-resistant isolates of Pseudomonas aeruginosa in a community-based hospital

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

Non-hospital consumption of antibiotics in Spain: 1987-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

[Trends in antibiotic consumption in Spain, 1985-2000]

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

Prevention of neural-tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

Ciprofloxacin treatment failure in typhoid fever case, Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

Levofloxacin treatment failure in Haemophilus influenzae pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

[Selection of antibiotic-resistant bacteria: microbiological and pharmacological factors]

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001).

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973066-9

7 January 2021

10.1016/S0213-005X(04)73066-9

Identifiers

DOI

1 reference

6 December 2017

1 reference